SCHEDULE 13G/A: Brown Capital Management Discloses 9.02% Stake in Cryoport Inc.

Brown Capital Management, LLC has filed an amended Schedule 13G, reporting a 9.02% beneficial ownership stake in Cryoport Inc. as of December 31, 2024.

Summary

• Brown Capital Management, LLC reported beneficial ownership of 4,458,774 shares of Cryoport Inc. common stock.
• This ownership represents 9.02% of Cryoport Inc.'s outstanding common stock.
• The filing indicates that Brown Capital Management, LLC holds sole voting power over 2,115,018 shares and sole dispositive power over all 4,458,774 shares.
• The shares were acquired and are held in the ordinary course of business, and not for the purpose of changing or influencing the control of Cryoport Inc.
• The event date requiring this filing was December 31, 2024, with the statement signed on February 14, 2025.

Sentiment

Score: 7

Explanation: The filing indicates a significant, passive investment by a reputable institutional investor, which is generally a positive signal of confidence in the company, though it provides no operational or financial performance details.

Positives

• A significant institutional investor, Brown Capital Management, LLC, holds a substantial stake (9.02%) in Cryoport Inc., which can be interpreted as a vote of confidence in the company's long-term prospects.
• The filing confirms that the shares are held for investment purposes in the ordinary course of business, indicating a passive investment rather than an activist or control-oriented intention.

Future Outlook

This Schedule 13G filing does not contain forward-looking statements or guidance regarding Cryoport Inc.'s future outlook, as its primary purpose is solely to report beneficial ownership by an institutional investor.

Industry Context

This filing indicates a significant passive investment by Brown Capital Management, LLC in Cryoport Inc., a company operating in the specialized life sciences logistics sector. Such institutional ownership is a common occurrence for publicly traded companies and can signal investor confidence in the industry's growth prospects, particularly in areas like cold chain logistics for biopharmaceuticals and cell & gene therapies.

Stakeholder Impact

• Shareholders: Increased institutional ownership may be viewed positively, potentially enhancing stock liquidity and stability.
• Company Management: Awareness of a significant passive investor on their shareholder register.

Key Dates

Keywords

Cryoport Inc., Brown Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Investment Adviser